Why two states struggled to eliminate hepatitis C, despite new approaches to paying for costly drugs
Here & Now‘s Anthony Brooks speaks with Nicholas Florko from our partners at STAT about two states that tried to eliminate hepatitis C despite the high cost of new cures.
This article was originally published on WBUR.org.
Copyright 2022 NPR. To see more, visit https://www.npr.org.